Banghulot, Donna Marie .
HRN: 21-39-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2022
CEFTAZIDIME 1GM (VIAL)
07/13/2022
07/20/2022
IV
117mg
Q8H
NEONATAL PNEUMONIA
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes